-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on CG Oncology, Raises Price Target to $120

Benzinga·11/19/2026 14:30:22
Listen to the news
Guggenheim analyst Michael Schmidt maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $89 to $120.